Report Categories
View AllRecent Articles
View All
Msle Stock Analysis Satellos Bioscience Inc. 2.81 Pct Dip To 5.87 Key Insights 20260403 1
The opportunity most miss about Nuwellis NUWE Technical Weakness 20260511
Xunlei XNET Stock Performance Drivers Analysis
MENS Jyong Biotech drops 369 on weak Q1 2025 earnings marked by zero revenue and negative EPS
JBT Marel JBTM Stock 52Week Low Calm 20260420
JDcom Inc JD PostRally Underperformance Upcoming Earnings Catalyst and Valuation Outlook
Edison International EIX Q1 Earnings Beat Reaffirmed Guidance Support Bullish Outlook Despite Minor Barclays Price Target Adjustment
The competitive moat visible in Powell Max PMAX earnings PMAX Latest Quarter Earnings Powell Max delays earnings release amid internal review
QRVO Qorvo posts 151 percent Q1 2026 EPS beat shares jump 895 percent amid positive investor sentiment
ENVX Enovix Corporation reports narrower Q4 2025 loss than analyst estimates shares rise modestly on positive investor sentiment
Hydrofarm HYFM Q3 2025 Earnings Miss Sparks Concern
Baosheng BAOS Declines 662 Amid Market Weakness 20260515
Newbury NTWO Unchanged at 1062 RangeBound Trading 20260518
Is electroCore ECOR Still a Buy After 154 Rally 20260519
Taiwan Stocks Surge as Weighted Index Gains 218 on Broad Market Rally
Kashkari Warns Middle East Energy Risks May Prolong Feds Cautious Stance
AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests
Infrastructure Control Emerges as Potential Key to Financial Edge
Indian Stock Market Faces Profit Booking After ThreeDay Rally
Vietnams Counterfeiting and Piracy Issues Persist Ahead of US Tariff Deadline
OCFC Q1 2026 Earnings EPS Beat of 591 Highlights Resilience Amid Slight Stock Decline
Teleflex TFX Q1 2026 Earnings EPS Beats Estimates by 14 as Stock Dips on Cautious Sentiment
BKD Q1 2026 Earnings EPS Misses Estimates as Senior Living Operator Navigates Cost Headwinds
MRNA Q1 2026 Earnings NarrowerThanExpected Loss Despite Revenue Absence
Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges